Prognostic Values of Baseline ¹⁸F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma

Table 5

Multivariate analysis for survivals.

	PFS				OS
	HR	95% CI			HR	95% CI
TMTV
TMTV	7.061	2.464-20.229	<0.001	TMTV	5.026	1.538-16.421	0.008
SUVmax	—	—	0.096	SUVmax	3.161	1.197-8.346	0.020
	—	—	0.229	NCCN-IPI	3.112	1.109-8.732	0.031
IPI	—	—	0.233		—	—	0.499
NCCN-IPI	—	—	0.515	IPI	—	—	0.856
				PIT	—	—	0.409
				Age	—	—	0.299
TLG
TLG	11.562	3.218-41.542	<0.001	TLG	11.609	2.595-51.930	0.001
SUVmax	—	—	0.794	SUVmax	—	—	0.360
	—	—	0.206		—	—	0.052
IPI	—	—	0.398	NCCN-IPI	—	—	0.325
NCCN-IPI	—	—	0.794	IPI	—	—	0.216
				PIT	—	—	0.703
				Age	—	—	0.170

Note: Statistically significant. Abbreviations: ECOG: Eastern Cooperative Oncology Group; BM: bone marrow; IPI: International Prognostic Index; NCCN-IPI: National Comprehensive Cancer Network International Prognostic Index; PIT: prognostic index for T-cell lymphoma.